Bionano Genomics (BNGO) Revenue (2017 - 2026)

Bionano Genomics' Revenue history runs 10 years deep, the most recent figure standing at $6.7 million for Q1 2026.

• In Q1 2026, Revenue rose 3.56% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $28.7 million (up 0.96% YoY), while the FY2025 annual figure was $28.5 million, down 7.37% from the prior year.
• Revenue came in at $6.7 million for Q1 2026 at Bionano Genomics, down from $8.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $10.7 million in Q4 2023 to a low of $5.7 million in Q1 2022.
• A 5-year average of $7.6 million and a median of $7.4 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 79.8% in 2022 and slumped 34.83% in 2024, its largest moves.
• Bionano Genomics' Revenue stood at $8.2 million in 2022, then surged by 30.51% to $10.7 million in 2023, then slipped by 23.86% to $8.2 million in 2024, then decreased by 2.6% to $8.0 million in 2025, then retreated by 15.9% to $6.7 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $6.7 million, $8.0 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison